IRONWOOD PHARMACEUTICALS, INC. Accrued Vacation, Current
IRONWOOD PHARMACEUTICALS, INC. (IRWD) had Accrued Vacation, Current of $2.19 million as of 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Notes › Payables and Accruals › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current › Employee-related Liabilities, Current
us-gaap:AccruedVacationCurrent · last filed 2021-11-04
- 2021-09-30: Accrued Vacation, Current $2.19M.
- 2021-06-30: Accrued Vacation, Current $2.40M.
- 2021-03-31: Accrued Vacation, Current $2.61M.
- 2020-12-31: Accrued Vacation, Current $2.63M.
| Period end | Accrued Vacation, Current | Accrued Vacation, Current as first filed |
|---|---|---|
| 2021-09-30 | $2.19M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $2.40M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $2.61M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $2.63M 10-Q · filed 2021-11-04 | |
| 2020-09-30 | $3.36M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $3.48M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $3.01M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $2.54M 10-K · filed 2021-02-17 | |
| 2019-09-30 | $2.65M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $2.89M 10-Q · filed 2019-07-30 | |
| 2019-03-31 | $4.38M 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $3.49M 10-K · filed 2020-02-13 | $4.10M 10-K · filed 2019-02-25 |
| 2018-09-30 | $3.83M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $4.87M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $4.82M 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $4.67M 10-K · filed 2019-02-25 | |
| 2016-12-31 | $4.01M 10-K · filed 2018-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |